Search clinical trials for: 4mg of Albuterol

Total 160964 results

GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Netherlands, Greece, Czechia
Amphastar Pharmaceuticals, Inc.

Completed

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation (A006-B3)

Asthma

United States
GlaxoSmithKline

Completed

A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma

Asthma

United States, Germany, Bulgaria, Peru, Mexico, Poland
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Asthma

United States, Canada
Vanderbilt University Medical Center

Withdrawn

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children

Asthma

United States
GlaxoSmithKline

Withdrawn

A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

Asthma
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Asthma

United States
Sunovion

Completed

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects (POLARIS)

Asthma | COPD

United States
Bio-Thera Solutions

Completed

Clinical Study on the Efficacy and Safety of BAT5906 Injection

Wet Age-related Macular Degeneration

China
EnnovaBio Australia Pharmaceuticals Pty Ltd

Completed

A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects

Healthy

Australia
J2H Biotech

Completed

Phase 1 Study to Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

Non-alcoholic Steatohepatitis

Korea, Republic of
Medicines for Malaria Venture
Asociacion Civil Selva Amazonica

Completed

DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax

Plasmodium Falciparum Malaria | Plasmodium Vivax Malaria

Peru
Amgen

Withdrawn

AMG 745 in Subjects With Age-associated Muscle Loss

Age-associated Muscle Loss
Abalonex, LLC

Not yet recruiting

Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury | Cerebral Edema
Rigel Pharmaceuticals

Completed

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (SITAR)

Asthma

United States, Canada
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Recruiting

Phase 1 Study of KH607 Tablets

Healthy

China
Hanmi Pharmaceutical Company Limited

Completed

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet (PGP inhibitor)

Healthy

Korea, Republic of
Sunovion

Completed

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada
Organon and Co
Integrated Therapeutics Group

Completed

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Asthma | Rhinitis, Allergic, Seasonal
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence

Completed

Treatment of Multiple Sclerosis With Copaxone and Albuterol

Multiple Sclerosis | Autoimmune Diseases

United States
Boehringer Ingelheim

Completed

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States
Imperial College London
GlaxoSmithKline

Terminated

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
Boehringer Ingelheim

Completed

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Lithuania, Slovakia, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Drug Study of Albuterol to Treat Acute Lung Injury (ALTA)

Respiratory Distress Syndrome, Adult

United States
JW Pharmaceutical
Chonbuk National University Hospital; Samsung Medical Center; Asan Medical Center and other collaborators

Completed

to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (SIPHON)

HbA1c Level Associated With Lipid Compositions

Korea, Republic of
AstraZeneca
Premier HealthCare Solutions Inc.

Recruiting

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care (ANCHOR)

Asthma

United States
Seton Healthcare Family
University of Texas

Completed

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

Asthma

United States
GlaxoSmithKline

Completed

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

Asthma

Poland, Romania, Russian Federation, United States, Canada
GlaxoSmithKline

Completed

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Australia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
GlaxoSmithKline
Parexel

Withdrawn

The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma

Asthma
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Asthma

United States, Argentina, Russian Federation, Mexico, France, Chile
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Bronchodilator Responsiveness in Obliterative Bronchiolitis (BD-OB)

Obliterative Bronchiolitis

Italy
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

Asthma

United States
Buddhist Tzu Chi General Hospital

Completed

Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

Overactive Bladder

Taiwan
CHA University
Merck Sharp & Dohme LLC

Completed

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

Mild Persistent Asthma
GeneScience Pharmaceuticals Co., Ltd.
Peking University People's Hospital

Completed

A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

China
Novartis Pharmaceuticals

Withdrawn

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

Asthma
Mannkind Corporation

Completed

A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

Diabetes Mellitus | Healthy Subjects

United Kingdom
Merck Sharp & Dohme LLC

Completed

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

Asthma
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) (TREXA)

Asthma

United States
Sanofi
Regeneron Pharmaceuticals

Completed

An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

Asthma

Spain, United States, Chile, Australia, France, Mexico, Argentina, Italy, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, Korea, Republic of, New Zealand
Philip Morris Products S.A.

Completed

Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

Pharmacokinetics

Russian Federation
University of Illinois at Chicago
Agency for Healthcare Research and Quality (AHRQ)

Completed

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study) (REDEFINE)

COPD Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Asthma

United States, Germany, Hungary, Poland
Chang Gung University
Chang Gung Memorial Hospital

Completed

Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation

Chronic Obstructive Pulmonary Disease

Taiwan
NYU Langone Health

Completed

The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia

Familial Dysautonomia

United States
Merck Sharp & Dohme LLC

Completed

Study of Biomarkers of Airway Inflammation (0000-128)

Airway Inflammation
Otsuka Pharmaceutical Development & Commercialization...

Completed

PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia

Schizophrenia

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Diabetes Mellitus, Type 2

United States, Estonia, Germany, Latvia, Spain, United Kingdom
Human Genome Sciences Inc.

Completed

A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

Hepatitis C

United States

3

Subscribe